Substance / Medication

Insulin lispro protamine

Overview

Active Ingredient
insulin lispro protamine, human
RxNorm CUI
314684

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

948 trials linked to this intervention

948
Total Trials
110
Recruiting
300
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
Ceriello Antonio, Cremasco Francesco, Romoli Ester et al. · Expert Opin Pharmacother · 2012
PMID: 22242803Meta-Analysis
Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes.
Hompesch Marcus, Ocheltree Scott M, Wondmagegnehu Eshetu T et al. · Curr Med Res Opin · 2009
PMID: 19761358RCT
Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
Dalfrà Maria Grazia, Soldato Angela, Moghetti Paolo et al. · J Matern Fetal Neonatal Med · 2016
PMID: 25817082Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Insulin lispro protamine (substance)
SNOMED CT
426313003
UMLS CUI
C0982221
RxNorm CUI
314684

Clinical Data

This intervention maps to 13 entities in the Ltrl knowledge graph.

4
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
948
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.